Skip to search formSkip to main contentSkip to account menu

astressin

Known as: cyclo(30-33)(Phe(12),Nle(21,38),Glu(30),Lys(33))r-hCRF(12-41) 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Corticotropin-Releasing HormoneNeuroprotective AgentsPeptide Fragments

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Mechanisms of hypothalamic regulation of food intake in birds
Academic) Energy homeostasis is essential for survival across all vertebrate species and involves a multitude of physiological… 
2017
2017
Effect of astressin, a corticoliberin antagonist, on aggression and anxiety-fobic states in male rats reared in social isolation
Aim . Intraspecific behavior, emotional and explorative activity were investigated after intranasal administration of astressin… 
2016
2016
[GASTROPROTECTIVE EFFECT OF CORTICOTROPIN-RELEASING FACTOR IN STREPTOZOTOCIN-INDUCED DIABETIC RATS].
The results of our previous studies suggest that corticotropin-releasing factor (CRF) protects the gastric mucosa of rats against… 
2011
2011
[The extended amygdala system and self-stimulation of the lateral hypothalamus in rats: modulation with opiates and opioids].
Wistar male rats were implanted with bipolar electrodes in the lateral hypothalamus to study self-stimulation reaction in the… 
2011
2011
[Significance of CRF and dopamine receptors in amygdala for reinforcing effects of opiates and opioids on self-stimulation of lateral hypothalamus in rats].
Bipolar electrodes were implanted in the lateral hypothalamus in a group of 44 Wistar male rats in order to study self… 
2008
2008
Astressin and beta-endorphin for use as therapeutic agents
1. Combination of the peptides D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-cyclo (-Glu-Ala-His -Lys… 
2008
2008
Astressin and beta-endorphin for use as therapeutic agents
The present invention is directed to the use of the peptide compound D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu… 
2006
2006
The Phenotypic Differentiation of Locus Coeruleus Noradrenergic Neurons Mediated by BDNF is Enhanced by Corticotropin Releasing Factor through the Activation of a cAMP-Dependent Signaling Pathway
factor; DA 
2006
2006
[Astressin blockade of amygdaloid corticoliberin receptors eliminates the stimulating effects of amphetamine, morphine and leu-enkephalin on brain self-stimulation].
Amphetamine (1 mg/kg), morphine (1 mg/kg), and ethaminal sodium (5 mg/kg) activated self-stimulation reaction of lateral… 
2003
2003
S tress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice
Objective: Interleukin-6 (IL-6) is elevated in the serum of patients with coronary artery disease (CAD) and acute coronary…